No Detectable Improvements in Cystic Fibrosis Transmembrane Conductance Regulator by Nasal Aminoglycosides in Patients with Cystic Fibrosis with Stop Mutations

Cystic fibrosis (CF) is an autosomal recessive disorder caused by many types of genetic defects, including premature stop codons. Gentamicin can suppress stop mutations in CF transmembrane conducatnce regulator (CFTR) in vitro and in vivo, leading to improvements in CFTR-dependent ion transport and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Clancy, John P., Rowe, Steven M., Bebok, Zsuzsa, Aitken, Moira L., Gibson, Ron, Zeitlin, Pam, Berclaz, Pierre, Moss, Rick, Knowles, Michael R., Oster, Robert A., Mayer-Hamblett, Nicole, Ramsey, Bonnie
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Thoracic Society 2007
Schlagworte:
Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1899350/
https://ncbi.nlm.nih.gov/pubmed/17347447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1165/rcmb.2006-0173OC
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge